🇺🇸 Insulin-Levemir in United States

29 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Fall — 4 reports (13.79%)
  2. Asthenia — 3 reports (10.34%)
  3. Confusional State — 3 reports (10.34%)
  4. Diarrhoea — 3 reports (10.34%)
  5. Dizziness — 3 reports (10.34%)
  6. Drug Dose Omission — 3 reports (10.34%)
  7. Pain In Extremity — 3 reports (10.34%)
  8. Product Quality Issue — 3 reports (10.34%)
  9. Abdominal Pain — 2 reports (6.9%)
  10. Acute Kidney Injury — 2 reports (6.9%)

Source database →

Other Diabetes approved in United States

Frequently asked questions

Is Insulin-Levemir approved in United States?

Insulin-Levemir does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Insulin-Levemir in United States?

Novo Nordisk A/S is the originator. The local marketing authorisation holder may differ — check the official source linked above.